NEOGEN CORP (NEOG) Fundamental Analysis & Valuation
NASDAQ:NEOG • US6404911066
Current stock price
9.63 USD
+0.12 (+1.26%)
At close:
9.63 USD
0 (0%)
After Hours:
This NEOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NEOG Profitability Analysis
1.1 Basic Checks
- In the past year NEOG was profitable.
- In the past year NEOG had a positive cash flow from operations.
- In multiple years NEOG reported negative net income over the last 5 years.
- NEOG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of NEOG (-18.12%) is comparable to the rest of the industry.
- With a Return On Equity value of -28.96%, NEOG perfoms like the industry average, outperforming 55.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.12% | ||
| ROE | -28.96% | ||
| ROIC | N/A |
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NEOG's Gross Margin of 45.20% is on the low side compared to the rest of the industry. NEOG is outperformed by 60.96% of its industry peers.
- In the last couple of years the Gross Margin of NEOG has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for NEOG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
2. NEOG Health Analysis
2.1 Basic Checks
- NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for NEOG remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, NEOG has more shares outstanding
- The debt/assets ratio for NEOG is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.15, we must say that NEOG is in the distress zone and has some risk of bankruptcy.
- NEOG has a Altman-Z score (1.15) which is in line with its industry peers.
- The Debt to FCF ratio of NEOG is 129.92, which is on the high side as it means it would take NEOG, 129.92 years of fcf income to pay off all of its debts.
- NEOG has a Debt to FCF ratio of 129.92. This is in the better half of the industry: NEOG outperforms 65.24% of its industry peers.
- NEOG has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.38, NEOG perfoms like the industry average, outperforming 44.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 129.92 | ||
| Altman-Z | 1.15 |
ROIC/WACCN/A
WACC8.04%
2.3 Liquidity
- A Current Ratio of 3.92 indicates that NEOG has no problem at all paying its short term obligations.
- NEOG has a Current ratio of 3.92. This is in the better half of the industry: NEOG outperforms 63.10% of its industry peers.
- A Quick Ratio of 2.84 indicates that NEOG has no problem at all paying its short term obligations.
- The Quick ratio of NEOG (2.84) is better than 60.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.92 | ||
| Quick Ratio | 2.84 |
3. NEOG Growth Analysis
3.1 Past
- The earnings per share for NEOG have decreased strongly by -26.32% in the last year.
- NEOG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.20% yearly.
- NEOG shows a decrease in Revenue. In the last year, the revenue decreased by -3.91%.
- Measured over the past years, NEOG shows a quite strong growth in Revenue. The Revenue has been growing by 16.43% on average per year.
EPS 1Y (TTM)-26.32%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.91%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-4.43%
3.2 Future
- NEOG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.29% yearly.
- The Revenue is expected to decrease by -0.50% on average over the next years.
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue Next Year-3.76%
Revenue Next 2Y-2.53%
Revenue Next 3Y-2.01%
Revenue Next 5Y-0.5%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. NEOG Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 34.39, which means the current valuation is very expensive for NEOG.
- 71.12% of the companies in the same industry are more expensive than NEOG, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.95. NEOG is valued slightly more expensive when compared to this.
- A Price/Forward Earnings ratio of 28.39 indicates a quite expensive valuation of NEOG.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 74.33% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of NEOG to the average of the S&P500 Index (38.68), we can say NEOG is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.39 | ||
| Fwd PE | 28.39 |
4.2 Price Multiples
- 68.45% of the companies in the same industry are more expensive than NEOG, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, NEOG is valued a bit cheaper than the industry average as 65.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 343.3 | ||
| EV/EBITDA | 34.16 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.38%
EPS Next 3Y9.52%
5. NEOG Dividend Analysis
5.1 Amount
- No dividends for NEOG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NEOG Fundamentals: All Metrics, Ratios and Statistics
9.63
+0.12 (+1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-09 2026-04-09/bmo
Earnings (Next)07-27 2026-07-27/amc
Inst Owners104.08%
Inst Owner Change2.17%
Ins Owners0.65%
Ins Owner Change21.99%
Market Cap2.10B
Revenue(TTM)870.54M
Net Income(TTM)-608.78M
Analysts78.18
Price Target11.48 (19.21%)
Short Float %4.67%
Short Ratio3.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.85%
Min EPS beat(2)53.45%
Max EPS beat(2)78.25%
EPS beat(4)3
Avg EPS beat(4)48.29%
Min EPS beat(4)-34.64%
Max EPS beat(4)96.08%
EPS beat(8)4
Avg EPS beat(8)19.98%
EPS beat(12)5
Avg EPS beat(12)49.94%
EPS beat(16)7
Avg EPS beat(16)44.82%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)1.26%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)1.83%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)5.99%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)5
Avg Revenue beat(12)0.05%
Revenue beat(16)5
Avg Revenue beat(16)-0.5%
PT rev (1m)2.27%
PT rev (3m)2.27%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-20%
EPS NY rev (1m)0%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.29%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.39 | ||
| Fwd PE | 28.39 | ||
| P/S | 2.41 | ||
| P/FCF | 343.3 | ||
| P/OCF | 30.14 | ||
| P/B | 1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 34.16 |
EPS(TTM)0.28
EY2.91%
EPS(NY)0.34
Fwd EY3.52%
FCF(TTM)0.03
FCFY0.29%
OCF(TTM)0.32
OCFY3.32%
SpS4
BVpS9.66
TBVpS-1.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.80061 (-19%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.12% | ||
| ROE | -28.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.2% | ||
| FCFM | 0.7% |
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
F-Score4
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 129.92 | ||
| Debt/EBITDA | 10.02 | ||
| Cap/Depr | 54.14% | ||
| Cap/Sales | 7.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 87.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.92 | ||
| Quick Ratio | 2.84 | ||
| Altman-Z | 1.15 |
F-Score4
WACC8.04%
ROIC/WACCN/A
Cap/Depr(3y)85.8%
Cap/Depr(5y)97.5%
Cap/Sales(3y)10.58%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.32%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-10%
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue 1Y (TTM)-3.91%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-4.43%
Revenue Next Year-3.76%
Revenue Next 2Y-2.53%
Revenue Next 3Y-2.01%
Revenue Next 5Y-0.5%
EBIT growth 1Y-254.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.34%
EBIT Next 3Y34.61%
EBIT Next 5Y20.01%
FCF growth 1Y146.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.1%
OCF growth 3Y-5.05%
OCF growth 5Y-7.47%
NEOGEN CORP / NEOG Fundamental Analysis FAQ
What is the fundamental rating for NEOG stock?
ChartMill assigns a fundamental rating of 3 / 10 to NEOG.
What is the valuation status of NEOGEN CORP (NEOG) stock?
ChartMill assigns a valuation rating of 3 / 10 to NEOGEN CORP (NEOG). This can be considered as Overvalued.
Can you provide the profitability details for NEOGEN CORP?
NEOGEN CORP (NEOG) has a profitability rating of 2 / 10.
How financially healthy is NEOGEN CORP?
The financial health rating of NEOGEN CORP (NEOG) is 5 / 10.
Can you provide the expected EPS growth for NEOG stock?
The Earnings per Share (EPS) of NEOGEN CORP (NEOG) is expected to decline by -9.33% in the next year.